סרטיקן ® 0.1 מ"ג טבליות מסיסות

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

EVEROLIMUS 0.1 MG

Available from:

NOVARTIS PHARMA SERVICES AG

ATC code:

L04AA18

Pharmaceutical form:

TABLETS DISPERSIBLE

Administration route:

PER OS

Manufactured by:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Therapeutic group:

EVEROLIMUS

Therapeutic indications:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Authorization date:

2010-02-01